Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 165 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location NCT ID

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Spinal Muscular Atrophy (SMA) Greece
Ireland
Israel
Poland
Portugal
Romania
Russia
South Korea
Taiwan
United States
View all

A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma

Asthma Phase3 Argentina
Austria
Bulgaria
Colombia
Czechia
Greece
Guatemala
Hungary
Italy
Mexico
Panama
Portugal
Romania
South Africa
Spain
Vietnam
View all

Home Reported Outcomes in PNH

Paroxysmal Nocturnal Hemoglobinuria United States

A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

Diffuse Cutaneous Systemic Sclerosis Phase2 Argentina
Austria
Belgium
Brazil
China
Colombia
France
Germany
Greece
Hungary
India
Italy
Japan
Malaysia
Mexico
Poland
Portugal
South Korea
Spain
Taiwan
Thailand
Turkey (Türkiye)
United Kingdom
United States
Vietnam
View all

A 24-week rPMS Study in Real-world Setting for Enerzair

Asthma South Korea

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma

Asthma Phase2 Bulgaria
Colombia
Guatemala
Hungary
Poland
South Africa
Spain
United Kingdom
View all

A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

Primary IgA Nephropathy Phase3 Brazil
Mexico
United States

Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials

Spinal Muscular Atrophy (SMA) Phase3 Australia
Belgium
Brazil
Canada
China
Denmark
France
Italy
Japan
Malaysia
Netherlands
Saudi Arabia
Singapore
Spain
Taiwan
Thailand
United Kingdom
United States
Vietnam
View all

A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast Cancer

Breast Cancer Jordan
Oman
Saudi Arabia
United Arab Emirates
View all

Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (CLEAR-AKI)

Acute Kidney Injury Due to Sepsis Phase2 Argentina
Australia
Austria
Belgium
Brazil
Canada
China
France
Germany
Hungary
India
Italy
Japan
Spain
Thailand
United Kingdom
United States
View all